JP2010523697A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523697A5
JP2010523697A5 JP2010503210A JP2010503210A JP2010523697A5 JP 2010523697 A5 JP2010523697 A5 JP 2010523697A5 JP 2010503210 A JP2010503210 A JP 2010503210A JP 2010503210 A JP2010503210 A JP 2010503210A JP 2010523697 A5 JP2010523697 A5 JP 2010523697A5
Authority
JP
Japan
Prior art keywords
composition
tumor
chemotherapeutic agent
irl
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010503210A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523697A (ja
JP5503528B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/059949 external-priority patent/WO2008127996A1/en
Publication of JP2010523697A publication Critical patent/JP2010523697A/ja
Publication of JP2010523697A5 publication Critical patent/JP2010523697A5/ja
Application granted granted Critical
Publication of JP5503528B2 publication Critical patent/JP5503528B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010503210A 2007-04-13 2008-04-10 癌の処置に寄与する方法および組成物 Expired - Fee Related JP5503528B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91177307P 2007-04-13 2007-04-13
US60/911,773 2007-04-13
PCT/US2008/059949 WO2008127996A1 (en) 2007-04-13 2008-04-10 Methods and compositions for contributing to the treatment of cancers

Publications (3)

Publication Number Publication Date
JP2010523697A JP2010523697A (ja) 2010-07-15
JP2010523697A5 true JP2010523697A5 (https=) 2011-05-26
JP5503528B2 JP5503528B2 (ja) 2014-05-28

Family

ID=39521878

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010503210A Expired - Fee Related JP5503528B2 (ja) 2007-04-13 2008-04-10 癌の処置に寄与する方法および組成物

Country Status (15)

Country Link
EP (1) EP2144607B1 (https=)
JP (1) JP5503528B2 (https=)
KR (1) KR20100016392A (https=)
CN (1) CN101686960A (https=)
AR (1) AR066048A1 (https=)
BR (1) BRPI0810215A2 (https=)
CA (1) CA2683890C (https=)
DK (1) DK2144607T3 (https=)
ES (1) ES2453295T3 (https=)
IL (1) IL201502A (https=)
MX (1) MX2009011041A (https=)
RU (1) RU2009141845A (https=)
TW (1) TWI439266B (https=)
WO (1) WO2008127996A1 (https=)
ZA (1) ZA200907083B (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2502848C (en) * 2002-10-24 2012-10-02 The Board Of Trustees Of The University Of Illinois Use of irl-1620 and paclitaxel for preventing and treating breast tumors
CA2598439A1 (en) * 2005-02-22 2006-08-31 The Board Of Trustees Of The University Of Illinois Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors

Similar Documents

Publication Publication Date Title
WO2009120697A4 (en) Method and compositions for treatment of cancer
JP2011515481A5 (https=)
JP2017171685A5 (https=)
PH12012501003B1 (en) Oxygen linked pyrimidine derivatives
RU2010140890A (ru) Улучшенные способы противоопухолевого лечения
JP2019521180A5 (https=)
JP2011079858A5 (https=)
NZ602382A (en) Methods of treatment of hepatocellular carcinoma
NZ598588A (en) Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
ME02470B (me) Nanočesтice nabijene sa hemoterapeutskim anтitumorskim lekom
NZ593343A (en) Combination cancer treatment conprising Abraxane and an inflamatory inhibitor
MX369728B (es) Métodos para mejorar suministro de fármacos y efectividad de agentes terapéuticos.
WO2007069272A3 (en) Pharmaceutical composition comprising at least one anticancer drug and at least one polymer
JP2005511597A5 (https=)
MX2014002555A (es) Una composicion farmacéutica para tratar cáncer, que comprende un conjugado de interferón alfa.
JP2015502926A5 (https=)
NZ603952A (en) Phosphaplatins and their use for treatment of cancers
TW200630105A (en) Herbal composition PHY906 and its use in chemotherapy
WO2009140675A3 (en) Combination therapy with pm00104 and another antitumor agent
JP2009545609A5 (https=)
JP2004523517A5 (https=)
RU2009107085A (ru) Способы, композиции и изделия, способствующие лечению рака
RU2010140611A (ru) Комбинированное применение производных холестанола
SI1803456T1 (sl) Farmacevtski sestavki, ki obsegajo L-733060, za uporabo pri zdravljenju rakavih tumorjev
JP2010523697A5 (https=)